- Home
- CNTX vs STRRP Comparison
CNTX vs STRRP Comparison
Compare CNTX & STRRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- STRRP
- Stock Information
- Founded
- CNTX 2015
- STRRP N/A
- Country
- CNTX United States
- STRRP United States
- Employees
- CNTX 9
- STRRP 171
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- STRRP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CNTX Health Care
- STRRP Health Care
- Exchange
- CNTX Nasdaq
- STRRP Nasdaq
- Market Cap
- CNTX 76.5M
- STRRP N/A
- IPO Year
- CNTX 2021
- STRRP N/A
- Fundamental
- Price
- CNTX $1.02
- STRRP $9.10
- Analyst Decision
- CNTX Strong Buy
- STRRP
- Analyst Count
- CNTX 4
- STRRP 0
- Target Price
- CNTX $7.38
- STRRP N/A
- AVG Volume (30 Days)
- CNTX 234.3K
- STRRP N/A
- Earning Date
- CNTX 11-06-2024
- STRRP N/A
- Dividend Yield
- CNTX N/A
- STRRP N/A
- EPS Growth
- CNTX N/A
- STRRP N/A
- EPS
- CNTX N/A
- STRRP N/A
- Revenue
- CNTX N/A
- STRRP N/A
- Revenue This Year
- CNTX N/A
- STRRP N/A
- Revenue Next Year
- CNTX N/A
- STRRP N/A
- P/E Ratio
- CNTX N/A
- STRRP N/A
- Revenue Growth
- CNTX N/A
- STRRP N/A
- 52 Week Low
- CNTX $0.89
- STRRP N/A
- 52 Week High
- CNTX $2.75
- STRRP N/A
- Technical
- Relative Strength Index (RSI)
- CNTX 17.93
- STRRP 46.18
- Support Level
- CNTX $1.17
- STRRP $9.07
- Resistance Level
- CNTX $1.61
- STRRP $9.36
- Average True Range (ATR)
- CNTX 0.11
- STRRP 0.05
- MACD
- CNTX -0.03
- STRRP 0.00
- Stochastic Oscillator
- CNTX 9.15
- STRRP 56.67
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About STRRP Star Equity Holdings Inc. Series A Cumulative Perpetual Preferred Stock
Star Equity Holdings Inc is a multi-industry diversified holding company with two segments: The construction segment manufactures modular housing units for commercial and residential applications. It operates in two businesses: modular building manufacturing and structural wall panel and wood foundation manufacturing, including building supply retail operations, and The investments segment holds corporate-owned real estate, which currently includes two manufacturing facilities in Maine that it leases back to KBS and manufacturing facility. The company derives maximum revenue from Construction Segment.